Fig. 4From: Serum proteomics as a strategy to identify novel biomarkers of neurologic recovery after cardiac arrest: a feasibility studyPooled serum proteomes 24 h after cardiac arrest. Little differences were observed in the proteomic phenotype of the pooled serum from patients with good neurological recovery (CPC 1–2, a) compared to patients with poor neurological recovery (CPC 3–5, b). Therefore, no protein spots were isolated for MSBack to article page